CARGO THERAPEUTICS

HQ - San Carlos, CA

Summary

CARGO Therapeutics is a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients.

Deals Overview

Total Deals2

Valued Deals1

Total Value£ 158 M

Avg. Deal Size£ 158 M

Market Context

Senior Management

Sort

Target: CARGO THERAPEUTICS

Bidder: THIRD ROCK VENTURES LLC

4 Service Providers

2 Dealmakers

£ 157 M

Value

Target: CARGO THERAPEUTICS

Bidder: CONCENTRA BIOSCIENCES

6 Service Providers

3 Dealmakers

n/a

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy